{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:10:12Z","timestamp":1789038612822,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Antimicrobial peptides (AMPs) are components in the innate immune system of various organisms, and many AMPs can be found in poisons from animals such as spiders, scorpions, and snakes. The peptide Cupiennin-1a is present in the venom of the spider <jats:italic>Cupiennius salei<\/jats:italic> and belongs to a group of peptides called cupiennins. The peptide demonstrated high cytotoxic activity against mammalian cells; thus, aiming to solve this problem, seven analogs were designed (R1a, R1b, R2b, R3b, R6b, R8b, and R10b) based on the primary structure of the peptide Cupiennin 1a, reducing its size and substituting some amino acid residues. The antimicrobial results showed that all Cupiennin 1a analogs displayed antimicrobial activity against the tested bacterial and fungal strains. Cytotoxicity tests demonstrated a decrease in the cytotoxic effect of the analogs when compared to the peptide Cupiennin-1a. The antitumor activity against breast adenocarcinoma lines was observed for all the peptides, displaying a better effect against the MCF-7 and MDAMB-231 cell lines. The eight peptides have insecticidal potential, and the original peptide and analogs R6b, R8b, and R10b showed better efficiency even at low concentrations. The rational design of the analogs led to new molecules displaying activities against different cell types and reduced cytotoxicity toward healthy mammalian cells when compared to the original peptide, demonstrating that this was an interesting approach for the development of molecules with biotechnological potential.<\/jats:p>","DOI":"10.3389\/fmicb.2022.850007","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:24:28Z","timestamp":1660803868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the biotechnological potential of peptide Cupiennin 1a and analogs"],"prefix":"10.3389","volume":"13","author":[{"given":"Rayssa Oliveira","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Lopes","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Tavares Baraviera","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolau","family":"Brito da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taia Maria Berto","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Henrique Soller","family":"Ramada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simoni Campos","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"ref1","author":"Adem Bahar","year":"2015"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"19282","DOI":"10.18535\/jmscr\/v5i3.153","article-title":"Designing antimicrobial peptide: current status","volume":"5","author":"Almsned","year":"2017","journal-title":"J. Med. Sci. Clin. Res."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/0929866526666190822165812","article-title":"Mini review on antimicrobial peptides, sources, mechanism and recent applications","volume":"27","author":"Boparai","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.biocontrol.2005.10.002","article-title":"Infectivity of Anticarsia gemmatalis nucleopolyhedrovirus to different insect cell lines: morphology, viral production, and protein synthesis","volume":"36","author":"Castro","year":"2006","journal-title":"Biol. Control"},{"key":"ref5","year":"2008"},{"key":"ref6","volume-title":"M7-A10 Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; Approved Standard - Tenth Edition","year":"2015"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/AAC.02218-12","article-title":"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens","volume":"57","author":"Deslouches","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref200","author":"Dutra","year":"2019"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1039\/c7np00020k","article-title":"Proline-rich antimicrobial peptides targeting protein synthesis","volume":"34","author":"Graf","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0041-0101(99)00167-1","article-title":"Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae)","volume":"38","author":"Haeberli","year":"2000","journal-title":"Toxicon"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.21873\/anticanres.11188","article-title":"In vitro and in vivo anticancer activity of human \u03b2-defensin-3 and its mouse homolog","volume":"36","author":"Hanaoka","year":"2016","journal-title":"Anticancer Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"11208","DOI":"10.1074\/jbc.M111099200","article-title":"Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae)","volume":"277","author":"Kuhn-Nentwig","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref300","author":"Kuhn-Nentwig","year":"2015","journal-title":"Spider Venoms, Toxinology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.toxicon.2013.03.003","article-title":"N-terminal aromatic residues closely impact the cytolytic activity of cupiennin 1a, a major spider venom peptide","volume":"75","author":"Kuhn-Nentwig","year":"2013","journal-title":"Toxicon"},{"key":"ref400","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00726-009-0471-0","article-title":"Cupiennin 1a exhibits a remarkably broad, non-stereospecific cytolytic activity on bacteria, protozoan parasite, insects, and human cancer cells","volume":"40","author":"Kuhn-Nentwig","year":"2011","journal-title":"Amino Acids"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02340-16","article-title":"Crossm intracellular targeting mechanisms by","volume":"61","author":"Le","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25184245","article-title":"Peptides with dual antimicrobial\u2013anticancer activity: strategies to overcome peptide limitations and rational design of anticancer peptides","volume":"25","author":"Liscano","year":"2020","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1021\/jm00099a001","article-title":"A general method for the preparation of internally quenched Fluorogenic protease substrates using solid-phase peptide synthesis","volume":"35","author":"Maggiora","year":"1992","journal-title":"J. Med. Chem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0006-3002(60)91464-5","article-title":"Note on spectrophotometric determination of proteins in dilute solutions","volume":"45","author":"Murphy","year":"1960","journal-title":"BBA Biochim. Biophys. Acta."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.12980\/apjtd.7.2017D7-15","article-title":"Biofilm formation and antimicrobial resistance in Klebsiella pneumoniae isolated from patients visiting a tertiary care center of Nepal","volume":"7","author":"Nepal","year":"2017","journal-title":"Asian Pacific J. Trop. Diase"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0185674","DOI":"10.1371\/journal.pone.0185674","article-title":"Anti-inflammatory and wound healing activities of calophyllolide isolated from Calophyllum inophyllum Linn","volume":"12","author":"Nguyen","year":"2017","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1002\/adfm.201202850","article-title":"Short Synthetic \u03b2-Sheet Forming Peptide Amphiphiles as Broad Spectrum Antimicrobials with Antibiofi lm and Endotoxin Neutralizing Capabilities","volume":"23","author":"Ong","year":"2013","journal-title":"Adv. Funct. Mater."},{"key":"ref23","first-page":"377","article-title":"Prediction and rational Design of Antimicrobial Peptides.","volume-title":"Protein Structure","author":"Porto","year":"2012"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","article-title":"1-S2.0\u22120092867478901010-Main.Pdf","volume":"15","author":"Raschke","year":"1978","journal-title":"Cell"},{"key":"ref25","first-page":"1","article-title":"Cell viability assays","volume-title":"Assay Guidance Manual","author":"Riss","year":"2016"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0006-3495(67)86579-2","article-title":"Use of helical wheels to represent the structures of proteins and to identify segments with helical potential","volume":"7","author":"Schiffer","year":"1967","journal-title":"Biophys. J."},{"key":"ref500","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00216-003-2057-0","article-title":"A novel MALDI LIFT-TOF\/TOF mass spectrometer for proteomics","volume":"376","author":"Suckau","year":"2003","journal-title":"Anal. Bioanal. Chem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1016\/j.jmb.2018.12.015","article-title":"Peptide design principles for antimicrobial applications","volume":"431","author":"Torres","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF02615077","article-title":"The establishment of two cell lines from the insect spodoptera frugiperda (lepidoptera; noctuidae)","volume":"13","author":"Vaughn","year":"1977","journal-title":"In Vitro"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.21105\/joss.01008","article-title":"Visualizing alpha-helical peptides in R with helixvis","volume":"3","author":"Wadhwa","year":"2018","journal-title":"J. Open Source Softw."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.biomaterials.2010.11.054","article-title":"Biomaterials synthetic cationic amphiphilic a -helical peptides as antimicrobial agents","volume":"32","author":"Wiradharma","year":"2011","journal-title":"Biomaterials"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1134\/S1068162020040044","article-title":"Antimicrobial peptide engineering: rational design, synthesis, and synergistic effect","volume":"46","author":"Ya\u2019u","year":"2020","journal-title":"Russ. J. Bioorganic Chem."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1021\/ci400477e","article-title":"Engineering antimicrobial peptides with improved antimicrobial and hemolytic activities","volume":"53","author":"Zhao","year":"2013","journal-title":"J. Chem. Inf. Model."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.850007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:24:37Z","timestamp":1660803877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.850007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":35,"alternative-id":["10.3389\/fmicb.2022.850007"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.850007","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"article-number":"850007"}}